Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 2 | +11K | 91.8% | $8.66 | +$95.1K |
Sells | 1 | -980 | 8.2% | $9.04 | -$8.86K |
Net | +1 | +10K | 83.6% | +$86.3K |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
James B. Breitmeyer | Chief Executive Officer, Director | $325K | Feb 14, 2024 | ||
Hale David F | Director | $283K | +$8.86K | +3.23% | Jun 20, 2024 |
Robert James Wills | Director | $89.6K | +$77.4K | +634% | Jun 20, 2024 |
Richard G. Vincent | Chief Financial Officer | $73.1K | Feb 14, 2024 | ||
Salim Yazji | Chief Medical Officer | $63.8K | Feb 14, 2024 | ||
Gunnar F. Kaufmann | Chief Scientific Officer | $47K | Jun 12, 2023 | ||
Chase C. Leavitt | General Counsel/Secretary | $42K | Feb 14, 2024 | ||
Rajesh Krishnan | Cto/Cso | $21.8K | Feb 14, 2024 | ||
Michael G. Carter | Director | Jun 20, 2024 | |||
Jinzhu Chen PhD | Director | Jun 16, 2022 | |||
Xin Nakanishi | Director | Jun 28, 2023 | |||
Rosemary Mazanet | Director | Jun 20, 2024 | |||
Charles Theuer | Director | Jun 20, 2024 | |||
William R. Larue | Director | Jun 20, 2024 | |||
Jill DeSimone | Director | Jun 20, 2024 | |||
Daniel L. Kisner | Director | Jun 20, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|